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Abstract 
Objective 
Observational studies indicate that moderate levels of alcohol consumption may reduce the 
risk of type 2 diabetes mellitus. In addition to updating the existing literature, this meta-
analysis explored whether reductions in risk may be the product of misclassification bias. 
Research design and methods 
A systematic search was undertaken, identifying studies that reported a temporal association 
between alcohol consumption and the risk of type 2 diabetes. No restrictions were placed 
upon the language or date of publication. Non-English publications were, where necessary, 
translated using online translation tools. 
Models were constructed using fractional polynomial regression to determine the dose-
response relationship between alcohol intake and type 2 diabetes, with a priori testing of sex 
and referent group interactions. 
Results 
Thirty-eight studiesmet the selection criteria, representing 1,902,605 participants and 
125,926 cases of type 2 diabetes. A conventional noncurrent drinking category was reported 
by 33 studies, while five reported a never-drinking category.  
Relative to combined abstainers, reductions in the risk of type 2 diabetes were present at all 
levels of alcohol intake <63 g/day, with risks increasing above this threshold. Peak risk 
reduction was present between 10–14 g/day at an 18% decrease in hazards. Stratification of 
available data revealed that reductions in risk may be specific to women only and absent in 
studies that adopted a never-drinking abstention category or sampled an Asian population 
region.  
Conclusions 
Reductions in risk among moderate alcohol drinkers may be confined to women and non-
Asian populations. Although based on a minority of studies, there is also the possibility that 
reductions in risk may have been overestimated by studies using a referent group 
contaminated by less healthy former drinkers.   
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Introduction 
Type 2 diabetes mellitus is associated with substantial increases in the risk of vascular 
morbidities, such as coronary heart disease and stroke (1), as well as health complications 
ranging from kidney failure and incontinence to limb loss and blindness (2). Collectively, 
approximately 12% of global health expenditure was spent on diabetes in 2010, or USD 376 
billion, rising to USD 490 billion over the next two decades (3). Such figures ignore the 
indirect costs of diabetes, including sickness absence, early retirement and demand for 
social care. 
Alongside established lifestyle factors, such as smoking (4), adiposity (5) and diet (6,7,8), 
alcohol consumption is also thought to  play a role in the development of type 2 diabetes. 
The most recent meta-analysis to have explored the alcohol-diabetes relationship was 
undertaken by Baliunas and colleagues in 2009 (9). Pooling data from 20 observational 
studies, they identified peak risk reduction at 24g/day (RR 0.60, 0.52–0.69) among women 
and 22g/day (RR 0.87, 0.76–1.00) among men, relative to never drinkers, with risk 
increasing in a dose-dependent manner above these levels.  
Several biological mechanisms have been proposed to explain the apparent reduction in risk 
of type 2 diabetes amongst moderate drinkers. These include the anti-inflammatory 
hypothesis, which posits that alcohol may beneficially alter the expression of inflammatory 
proteins implicated in metabolic processes (10), including adiponectin (11) and interleukin-
1β (12), and a possible stimulatory effect of alcohol upon the synthesis of high-density 
lipoprotein (11). However, studies investigating such mechanisms are subject to notable 
limitations, including short follow-up periods and small sample sizes, limiting the 
generalizability of findings both at the population level and over the long term (13). 
It is possible that reductions in risk identified between moderate alcohol exposure and 
incident type 2 diabetes may occur partly as an artefact of referent group selection, 
particularly where confounder adjustment is weak (14,15). To date, observational studies 
have commonly adopted pooled non-drinkers as the unexposed referent category. However, 
non-drinkers are far from homogeneous, comprising both never and former drinkers. Former 
drinkers are particularly notable, displaying poorer health and higher levels of mortality than 
moderate and never drinkers (16). Many existing alcohol-diabetes studies may have 
therefore overestimated the degree of risk reduction among moderate consumers of alcohol 
by comparing drinkers to a less healthy non-drinking referent category (17). Indeed, in a 
meta-analysis exploring the relationship between alcohol consumption and all-cause 
mortality, reductions in risk were attenuated when data were restricted to studies that 
excluded former drinkers from the referent category (18). Similar findings have been 
identified elsewhere (14,19). 
Although a preceding meta-analysis (9) attempted to overcome the methodological 
shortcoming of calculating risks relative to pooled non-drinkers, they did so only by weighting 
studies with non-drinking referent categories according to the sex-specific proportions of 
former drinkers reported by five studies for which such data were available. Of these five 
studies, just two had strictly defined never drinking as life-long abstention. It was unclear 
whether proportions of never drinkers drawn from five studies could be reliably applied to a 
multitude of disparate study populations. 
A new meta-analysis was thus undertaken. In addition to updating the pool of selected 
studies, this meta-analysis explicitly sought to test for differences in the dose-response 
relationship according to the choice of referent group and reports referent-specific 
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associations between average daily alcohol consumption and incident cases of type 2 
diabetes. 
Methods 
Data sources and searches 
PubMed (MEDLINE), Embase, The Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) and the Alcohol and Alcohol Problems Science (ETOH) databases were searched 
for relevant studies. 
Where possible, searches identified publications with titles or abstracts containing an 
alcohol-related term (‘alcohol’, ‘ethanol’ or ‘drink*’), plus a diabetes-related term (‘diabet*’, 
‘NIDDM’ or ‘T2D*’), plus a term indicative of longitudinal observational data (‘cohort’, 
‘inciden*’, ‘prospective’, ‘longitudinal’, ‘case’ or ‘retrospective’). No limits were placed upon 
the language or date of publication, and searches were undertaken on 18/02/2014. 
Unpublished literature, including conference abstracts and working papers, was not 
included. 
Of publications included in the final meta-analysis, referenced and referencing publications 
were searched for additional literature not captured by initial electronic searches. 
Study selection 
Types of study 
Cohort, case-cohort, case-control and nested case-control designs were eligible, and both 
community and occupational datasets were considered. Participants had to be adults aged 
≥16 years.  
Types of exposure 
Sex-specific self-reported alcohol consumption was selected as the exposure of interest. 
With non-linear relationships having previously been identified between alcohol consumption 
and type 2 diabetes (9), consumption needed to be reported across ≥3 categories, inclusive 
of a never or non-drinking group. Studies were excluded if consumption could not be 
converted into g/day, and if any abstention category was contaminated by current drinkers. 
Types of outcome 
Incident type 2 diabetes was selected as the outcome. Diagnostic tests and their respective 
thresholds have varied over time (20). Restricting selection to publications that defined type 
2 diabetes according to current recommendations would unnecessarily exclude earlier 
publications which adopted the gold standard of the period. Such an approach would also 
exclude self-reported outcome data. An inclusive range of measures were thus considered: 
all historic WHO recommendations, self- or doctor-reported diagnosis or anti-diabetic 
medication prescription, or linkage to clinical registry data. 
Shortlisting against selection criteria 
Duplicate publications were omitted and remaining publications screened to remove any that 
did not report a temporal association between alcohol exposure and either type 2 diabetes. 
Screened publications were then independently shortlisted against study selection criteria by 
two authors, with one-third reviewed by all three authors. Differences of opinion were 
resolved via the input of the third reviewer, and the majority decision upheld where a 
publication was reviewed by all three reviewers. The degree of agreement between 
reviewers was determined using the Cohen’s and Fleiss kappa (21) statistics. In all cases 
agreement was high (κ=≥0.815). 
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Data requests 
To limit the number of excluded publications, authors of studies that reported an alcohol-
diabetes relationship but did not meet selection criteria were contacted requesting revised 
analyses modified in accordance with selection criteria. 
Duplicate studies 
Duplicate studies were identified among shortlisted entries and omitted with consideration to 
the type and number of confounding factors, sample size and length of follow-up. Decisions 
were reached by consensus. 
Data extraction and quality assessment 
Data extraction 
Once eligible studies had been shortlisted, relevant characteristics and results were 
extracted and independently verified by a second reviewer. Extracted data included sample 
size, country, baseline age, sex, confounder adjustment, length of follow-up, and risk 
estimates for each exposure category. 
Measures of exposure 
Exposure reported in number of drinks was converted to g/day assuming country-specific 
standard drinks (22). Exposures categorised according to periods longer than a day were 
converted into daily estimates assuming an even distribution of consumption over the 
reference period. Where averages were not reported for each exposure category, the 
medians of the lower and upper limits were selected. For categories with no upper limit, 
median values were defined as 1.5 times the lower limit of the category (9).  
Measures of effect 
As odds ratios (ORs) approximate RRs only when the incidence of an outcome is low, 
published ORs and their respective CIs were adjusted according to the Zhang and Yu 
method (23). With hazard ratios (HRs) being a form of RR that is independent of study 
length (24),HRs were thus considered equivalent to RRs for the purpose of the meta-
analysis. 
Where publications reported a referent group other than never or non-current drinking, risk 
estimates were recalculated to ensure that risk estimates were each relative to the reference 
group of interest (25). Using the Hamling method accounted for the non-independence 
present between estimates that share the same reference category, thereby reducing any 
underestimation of variance during their recalculation (25, 26). Adjustment for this 
covariance was also undertaken during the calculation of meta-analytic models. 
Estimates were extracted from models that reported sex-specific risk across ≥3 categories of 
exposure and incorporated the maximum number of confounding variables without 
adjustment for potential mediators – i.e. markers of insulin, glucose or triglycerides. 
Quality assessment 
Study quality was assessed using the Newcastle-Ottawa quality assessment scale (27). It 
comprises eight questions grouped under three broad dimensions: selection of groups under 
study; comparability of groups under study; and outcome ascertainment. Questions range 
from the representativeness of the sample to the method of case ascertainment. A single 
point is awarded for each question bar that concerning the comparability of the groups under 
study, for which up to two points can be awarded. Study quality was thus determined on a 
scale from 0–9 points. A full list of questions and criteria used for determining study quality is 
provided in Supplemental Table S1. 
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The effect of study quality was explored by stratifying data according to whether or not 
studies were scored below the median value. 
Data synthesis and analysis 
Model selection 
Models were constructed using fractional polynomial regression, which permitted the 
expression of non-linear relationships (28). Building on a null model containing only a 
constant parameter, first-order and second-order polynomials were fitted for each analysis 
according to a restricted range of fractional powers. 
Fit for each analysis was determined according to the deviance statistic, equivalent to the 
sum of squared residuals under OLS regression, such that the best-fitting model was that 
which reported deviance closest to zero.  
Random effects 
All analyses were undertaken using random effects (29). The overall degree of heterogeneity 
present between studies was quantified using the I2 index (30). 
Small-study effects 
As asymmetry cannot be explored using continuous dose-response data, alcohol 
consumption was recoded into a drinking/non-drinking binary variable and risk estimates 
recalculated accordingly. The log of these new estimates were then plotted against the log 
standard error, with a summary estimate calculated according to a standard fixed-effect 
meta-analysis (31). For the purpose of identifying small-study effects, the use of a random-
effects weighting component is not recommended. Doing so would provide a greater relative 
weight to smaller studies and may mask any underlying asymmetry where sample size and 
the direction of a point estimate are associated (31).  
All analyses were performed using Stata v13 (StataCorp, Texas). 
Additional analyses 
In addition to the primary analysis of all pooled data combined, a priori consideration was 
given to the effect of sex- and referent-group, stratifying data by these explanatory factors 
where significant to the 0.05 level.  
Upon identifying a single study that contributed a substantial proportion of sampled data, an 
a posteriori sensitivity analysis was undertaken. This explored the effect of excluding the 
large study from the pooled analysis. 
A further a posteriori sensitivity analysis was undertaken to explore why male dose-response 
data appeared to differ from that reported previously (9). Male dose-response data were 
stratified according to whether they had been extracted from publications included in the 
2009 meta-analysis (n=17) or new publications sampled as part of this current meta-analysis 
(n=20). Although the 2009 meta-analysis sampled 20 publication, only 17 of these were 
included in this current meta-analysis. Of the three that were omitted, one did not appear to 
report sex-specific risk estimates, while two concerned studies for which newer data were 
available that benefitted from increased sampled size, longer follow-up or greater 
confounder adjustment. 
Finally, factors potentially contributing to any observed heterogeneity were investigated. 
These were thought to include participant age, method of case ascertainment, degree and 
type of confounder adjustment, follow-up duration, the healthy worker effect (32) and 
population region (33). Due to the risk of aggregation bias, only a subset of factors could be 
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explored in the absence of individual-level data (34). Data were stratified on each 
appropriate factor, with differences explored visually following adjustment for the effect of 
sex and reference group.  
Results 
Of an initial 2,704 results, 38 studies met a priori selection criteria: 33 used a conventional 
non-current drinking category and five included a never drinking category, strictly defined as 
zero consumption across the life course (Figure 1). Selected study characteristics are 
summarised in Supplemental Tables S2 and S3. Aggregate data were available for 
1,082,639 male and 819,966 female participants, among whom 79,633 and 46,293 cases of 
type 2 diabetes were reported. Crude or age-adjusted estimates were provided by 15 
studies. Of the remaining 23 studies, covariate adjustment was variable: adiposity (n=17), 
smoking (n=16), physical activity (n=15), heritability (n=10), education (n=9), dietary 
variables (n=6), blood pressure (n=5), ethnicity (n=3), and occupation (n=3).  
<INSERT FIGURE 1 (FLOW DIAGRAM) HERE> 
All data 
Data from all 38 studies are plotted in Figure 2. Studies each contributed at least three data 
points, inclusive of reference category, which were all plotted of a size inversely proportional to 
their standard error. Visual inspection suggested considerable between-study heterogeneity – 
an observation corroborated by an I2 of 75% (95% CI 67–80%) along the first-order polynomial, 
and 50% (95% CI 31–63%) along the second-order polynomial.  
Relative to all abstainers (current non-drinkers and never drinkers), a reduction in the risk of 
type 2 diabetes appeared present at all levels of alcohol intake <63g/day, with risks increasing 
above this threshold. Peak risk reduction was present between 10–14g/day, with an 18% 
decrease in risk relative to combined abstainers. The non-linear model offered a better 
parameterisation of the dose-response relationship than a linear regression (p=<0·001). 
<INSERT FIGURE 2 (ALL DATA)> 
Sex-specific data 
A sex-stratified scatter diagram of extracted data indicated a difference in the dose-response 
relationship by sex. A sex-interaction term was found to be significant (p=<0.001) and improved 
the fit of the model (p=<0.001).  
Sex-stratified results are presented in Figure 3 and indicate that any reduction in risk may be 
specific to women, who exhibited a decreased risk of type 2 diabetes at <71g/day and peak 
reduction of 34% at 31–37g/day, relative to combined abstainers. This equated to any level of 
alcohol consumption below around four pints of 4% ABV lager per day, with peak reduction at 
almost two pints of 4% ABV lager per day. For men, a shallow increase in risk appeared to be 
present from very low levels of consumption. 
<INSERT FIGURE 3 (SEX-SPECIFIC DATA)> 
Referent-specific data 
Few studies utilised a strictly-defined never-drinking category (men: four studies, n=15,766 (35, 
36, 37, 38); women: four studies, n=98,521 (35, 36, 37, 39)). The referent interaction was 
significant (p=0.005) and improved the fit of the model (p=0.02). Sex-adjusted, referent-stratified 
results are displayed in Figure 4. Consumption relative to never drinkers was associated with no 
reduction in the risk of type 2 diabetes at any level. By comparison, consumption of <59g/day 
showed a reduction in risk relative to non-current drinkers.  
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<INSERT FIGURE 4 (REFERENT-SPECIFIC DATA)> 
Sex-specific data (never drinking studies only) 
Having identified significant differences in dose-response by both sex and referent group, sex-
specific data from the five studies utilising a strictly-defined never drinking abstention category 
are reported in Supplemental Figure S1. 
Compared to the model reporting all sex-specific data combined (Figure 3), restricted analyses 
showed similar results but with greater imprecision. Consumption among men showed no 
reduction in risk at any level of exposure, with decreases specific to women and present across 
a narrower range of exposure (<61g/day). 
Small-study effects 
Funnel plots showed notable asymmetry among female data points, with the majority of smaller 
studies reporting a greater degree of risk reduction than the summary estimate, relative to 
pooled non-drinkers (data not shown). Given the recommendation that only a simple inverse 
variance weight be used when deriving the summary estimate, asymmetry was likely the 
product of a large Korean study, which provided 65% of participant data and reported a lower 
degree of risk reduction than most other studies (40). The impact of the Korean study upon 
modelled dose-response curves was diminished following the addition of a random effects 
weighting component in the primary analyses undertaken for this paper (Supplemental Figure 
S2). 
Quality assessment 
The quality of selected studies ranged from three to nine points out of nine, with a median score 
of six (Supplemental Table S3). Such a finding indicated broad discrepancies in study quality, 
with studies being of moderate quality on average. Sex and referent-adjusted stratification 
according to whether or not data were derived from a study with a score below the median 
value showed little difference in the dose-response relationship between both groups 
(Supplemental Figure S3). 
Putative sources of heterogeneity 
Method of case ascertainment was summarised as participant self-report (n=11), objective 
ascertainment (n=21), or a combination thereof (n=6). Given the small number of studies to 
have employed both methods, attention was focussed upon the subset utilising either self-
reported or objective outcome data. The sex- and referent- adjusted dose-response relationship 
of the 32 applicable studies was stratified according to these two categories of case 
ascertainment. Stratified sex- and referent-adjusted analyses showed a less pronounced 
reduction in risk among studies using objective outcome data compared with those that used 
self-reported case ascertainment (Supplemental Figure S4). 
The next factor thought to explain some degree of the observed between-study heterogeneity 
was whether data were extracted from an occupational (n=12) or general population (n=26) 
cohort. Although confidence intervals overlapped along the length of the fitted curves, effect 
estimates extracted from occupational cohorts appeared to show greater levels of risk reduction 
(Supplemental Figure S5). 
A total 15 studies reported crude or age-adjusted estimates (n=15), with 23 studies providing 
multivariable-adjusted data (n=23). Compared to a model based on crude or age-adjusted data, 
multivariable-adjusted data appeared to show less reduction in risk at moderate levels of 
alcohol consumption but with reductions in risk present across a broader range of exposure 
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(Supplemental Figure S6). This relationship was little changed when using an alternative 
confounding variable that defined studies according to whether their degree of adjustment was 
above or below the mean of four confounding factors.  
Finally, data were stratified according to whether effect estimates were extracted from an Asian 
(n=13) or non-Asian (n=25) population. No reduction in risk was found within data drawn from 
Asian populations, with reductions in risk being specific to participants from non-Asian regions 
(Supplemental Figure S7). 
Discussion 
The updated and expanded meta-analysis showed no reduction in type 2 diabetes risk at any 
level of alcohol consumption among men, regardless of reference group. This is in contrast to a 
2009 meta-analysis, which reported peak reduction in risk among men at 22g/day (RR 0.87, 
95% CI 0.76–1.00), relative to quasi-never drinkers (9). In order to explore this discrepancy, 
male data were stratified according to whether or not they had been included in the 2009 meta-
analysis (Supplemental Figure S8). These stratified dose-response data indicate that reductions 
in risk among lighter drinkers were particular to the studies sampled by the 2009 meta-analysis; 
among the 20 new studies added as part of the updated meta-analysis, no reduction in risk was 
present at any level of alcohol consumption, relative to pooled non-drinkers. Such a finding hints 
at marked heterogeneity between the two groups of publications. Based on supplementary 
analyses that investigated potential sources of heterogeneity (Supplemental Figures S3-7), the 
absence of any reduction in risk among newly sampled studies would be expected were they 
more likely to have sampled data from Asian populations or utilised objective methods of case 
ascertainment. 
Reductions in risk appeared to be specific to women, who exhibited a decreased risk of type 2 
diabetes at <71g/day and peak reduction of 34% at 31-37g/day, relative to combined abstainers 
(current non-drinkers and never drinkers). 
A reduction in risk being specific to female drinkers may be attributable to a number of factors. 
Firstly, that female never drinkers may be less healthy than their male equivalents. Although 
research concerning the health status of never drinkers is lacking, a recent paper analysing 
data from the National Child Development Study 1958 found that, of participants to consistently 
report longstanding illness from the age of 23 years, women were significantly more likely to 
report being never drinkers at age 33 and 42 years (41). Such data hint at the possibility that 
risk factors for type 2 diabetes may be disproportionately distributed between the sexes – a 
problem particularly pronounced for any estimates drawn from poorly adjusted studies. 
However, no sex-specific differences were identified in the average number of covariates 
adjusted for among selected studies. 
Secondly, exposure data analysed as part of this meta-analysis concerned average volume 
intake over a given time, and therefore did not capture the effect of episodic drinking behaviours 
upon the risk of type 2 diabetes. The importance of such a consideration is well illustrated, such 
as in a recent meta-analysis of ischemic heart disease (42). While a 36% reduction in risk was 
identified among moderate drinkers (<30g/day), no reduction was evident among moderate 
drinkers who also reported heavy episodic consumption (RR 1.12, 95% 0.91–1.37). This 
analysis mirrored findings from earlier studies (43,44), and suggests that a higher degree of 
heavy episodic drinking among men may go some way toward explaining observed sex-specific 
differences in the alcohol-diabetes relationship. Data collated from 172 European general 
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practices appear to support such a possibility, with the multivariable-adjusted odds of heavy 
episodic drinking being more than four times that of women (45). 
Thirdly, putative biological pathways may operate differently between men and women, such as 
the effect of alcohol consumption on insulin sensitivity. Following an analysis of results reported 
by 14 intervention studies, alcohol consumption was associated with reduced fasting insulin 
concentrations and improved insulin sensitivity among women only (13). However, findings from 
such intervention studies should be interpreted with caution owing to their small size, 
heterogeneous designs and populations, and often conflicting results (46). 
Fourthly, sex-specific differences in the dose-response relationship may have been attributable 
in part to disparities in the characteristics of studies from which male and female data were 
extracted, with 84.1% of male participants and 57.6% of female participants having been 
sampled from studies of Asian populations, and 13.6% and 34.1% of male and female 
participants having been sampled from studies utilising self-reported methods of case 
ascertainment. Supplementary analyses reported as part of this meta-analysis indicate that 
such factors may have an effect upon degree of observed risk reduction. For instance, 
reductions in risk were found to be particular to non-Asian populations (Supplemental Figure 
S7), which might be expected given impairments to alcohol metabolism (47) and a heightened 
genetic susceptibility among Asian populations to the development of T2DM (48). Furthermore, 
relative to studies utilising objective measures of case ascertainment, reductions in risk were 
greatest among those that relied upon self-reported measures (Supplemental Figure S4). 
However, although the data presented in Supplemental Figure S4 suggest that self-reported 
data may introduce an under-estimation of diabetes risk (49),recent studies have found self-
reported methods of case ascertainment to be valid and appropriate for use in epidemiological 
studies (50 51). 
Strengths 
This meta-analysis benefitted from the addition of 18 studies published since 2008 or otherwise 
missed or discounted during previous meta-analyses. This equated to an additional 1,425,356 
participants and 113,370 cases, relative to the last published meta-analysis in 2009 (9).  
While the previous meta-analysis may have adopted a never drinking referent category for the 
determination of risk among exposed participants, it afforded only an approximation of risk by 
weighting effect estimates relative to non-drinkers according to the sex-specific prevalence of 
former drinkers reported by five of the 20 selected studies to have reported never and former 
drinkers separately. This approach assumed that the proportion of former drinkers contained 
within a non-drinking category could be reliably estimated according to those reported by five 
studies and sex alone. Furthermore, just two of the five selected studies had strictly-defined 
never drinking as life-long abstention. 
Contrary to this approach, we explicitly tested for a referent-group interaction and, having 
identified a significant difference in the dose-response relationship according to the choice of 
referent group, sought to stratify risk estimates by abstention category (Figure 4). 
Limitations 
Heterogeneity between sampled studies was high, complicating interpretation. Factors likely to 
have contributed to between-study differences in dose-response were thought to include 
participant age, method of exposure and case ascertainment,  follow-up duration, the healthy 
worker effect of occupational cohorts, ethnicity, and both the degree and type of confounder 
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adjustment. For instance, more than a third (39%) of selected studies provided crude or age-
adjusted data, while just six studies (16%) gave consideration to the effect of dietary factors.  
Where the risk of aggregation bias was low in the absence of individual-level data (34), these 
likely sources of heterogeneity were explored visually via the stratification of dose-response 
curves. The resulting supplementary analyses (Supplemental Figures S3-S7) confirmed that 
reductions in risk were lowest among studies with greater levels of confounder adjustment and 
suggest that future studies exploring the alcohol-diabetes relationship should give greater 
consideration to the variables included. .  
The use of meta-regression to formally and jointly test of differences in dose-response 
according to putative sources of heterogeneity was avoided owing to the potential for low 
statistical power relative to regressions of individual-level data, even when effect sizes and the 
number of studies are large (34,52,53).  While it has been suggested that statistical power may 
be sufficient in instances where the number of covariates does not exceed a ratio of one to 
every 10 studies (54), simulations suggest that power is especially low when heterogeneity is 
high (55). 
Although the quality of selected studies was assessed using the Newcastle-Ottawa assessment 
scale (27), such tools are subject to notable limitations. For instance, although a wide range of 
instruments have thus far been devised for the assessment of non-randomised studies, each 
comprises assessment criteria that are disparate in both number and nature (56). In addition to 
the use of different rating scales or summary scores that risk weighing the importance of 
component items in ways not directly related to their impact upon the internal validity of a given 
study (57,58), their contrasting construction is such that the choice of tool may have a large 
bearing upon the assessment of study quality. Alongside the effect of such factors upon the 
interpretation of results derived from a quality assessment instrument, the Newcastle-Ottawa 
tool has received particular criticism. These criticisms range from the tool’s focus upon the 
generalisability of a given sample to the general population as opposed to its internal validity 
(59), to the arbitrary nature of some questions that appear to weaken inter-rater reliability 
(60,61). With these limitations in mind, the Newcastle-Ottawa quality assessment tool should be 
considered only as a rough guide for readers as opposed to a definitive measure of study 
quality. 
A further shortcoming rests with the limited number of studies to have explicitly separated 
former drinkers from strictly-defined never drinkers. Totalling just five unique studies, caution 
should be applied when drawing inferences based upon analyses that reported the dose-
response relationship by referent group.  
Regardless of the referent category selected, sampled studies consistently relied upon self-
reported alcohol consumption data, which is known to substantially under-report the amount of 
alcohol sold owing to factors such as questionnaire design (62) and a range of cognitive biases 
(63). In addition, by relying upon only a single cross-sectional self-report of alcohol 
consumption, sampled studies did not consider the effect of temporal changes in alcohol 
consumption both during the length of study and prior to study initiation. The assumption of 
stable temporal consumption is likely to be invalid, with disparate trajectories of alcohol 
consumption consistently identified regardless of the length of follow-up or the age of the cohort 
under study (64,65).  
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Conclusion 
Dose-response analyses exploring the association between alcohol consumption and incident 
type 2 diabetes have typically identified a reduction in risk at relatively moderate levels of 
exposure among both men and women. By contrast, the primary analyses undertaken as part of 
this meta-analysis suggest that reductions in risk at moderate levels of alcohol consumption 
drinkers may be confined to women, with a series of sex-adjusted supplementary analyses 
indicating that reductions in risk may be greatest among studies that utilised self-reported 
methods of case ascertainment or sampled individuals from non-Asian populations.  
In addition, the analyses also hinted at the possibility that many existing analyses may have 
overestimated the degree to which the risk of type 2 diabetes is reduced among moderate 
consumers of alcohol, with reductions in risk appearing to be specific to studies utilising a non-
current drinking referent category. Unfortunately, very few studies have excluded less healthy 
former drinkers from the abstention category, limiting the inferences than can be drawn from the 
stratification of data by abstention group. 
Further research is now required to better understand sex-specific differences in the dose-
response relationship between alcohol consumption and type 2 diabetes. Such research will be 
aided by the application of detailed trajectory-based analyses capable of modelling the effect of 
changes to alcohol exposure as a function of time. Until then, however, policy-makers, medical 
professionals and the general public should apply caution before considering moderate alcohol 
consumption as conferring individuals with a reduction in metabolic risk. 
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